Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 21,700 Shares of Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Amy W. Schulman sold 21,700 shares of Alnylam Pharmaceuticals stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $148.60, for a total value of $3,224,620.00. Following the transaction, the director now directly owns 8,436 shares of the company’s […]
More Stories
Wedbush Trims IGM Biosciences (NASDAQ:IGMS) Target Price to $22.00
IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target trimmed by Wedbush from $25.00 to $22.00 in a research...
Oppenheimer Increases Onto Innovation (NYSE:ONTO) Price Target to $275.00
Onto Innovation (NYSE:ONTO – Free Report) had its target price raised by Oppenheimer from $260.00 to $275.00 in a research...
Gritstone bio (NASDAQ:GRTS) Receives Neutral Rating from HC Wainwright
HC Wainwright restated their neutral rating on shares of Gritstone bio (NASDAQ:GRTS – Free Report) in a report published on...
Evercore ISI Raises KeyCorp (NYSE:KEY) Price Target to $20.00
KeyCorp (NYSE:KEY – Free Report) had its target price lifted by Evercore ISI from $18.50 to $20.00 in a report...
JPMorgan Chase & Co. Begins Coverage on Diamondback Energy (NASDAQ:FANG)
JPMorgan Chase & Co. began coverage on shares of Diamondback Energy (NASDAQ:FANG – Free Report) in a research note published...
Deutsche Bank Aktiengesellschaft Increases BWX Technologies (NYSE:BWXT) Price Target to $129.00
BWX Technologies (NYSE:BWXT – Get Free Report) had its target price raised by equities researchers at Deutsche Bank Aktiengesellschaft from...